Transaction in Own Shares

Summary by AI BETAClose X

On September 9, 2025, GSK plc, executing its existing buyback program, purchased 207,767 of its own ordinary shares with a nominal value of 31¼ pence each. The shares were bought on the London Stock Exchange at prices ranging from 1,468.50p to 1,490.50p, with a volume-weighted average price of 1,483.93p. These shares will be held as treasury shares. Since June 4, 2025, the company has bought back 28,019,060 ordinary shares. Following this transaction, GSK holds 246,153,443 ordinary shares in treasury, with 4,069,248,284 ordinary shares in issue, excluding treasury shares; the percentage of voting rights attributable to treasury shares is 6.05 percent. The total number of voting rights in the company is 4,069,248,284.

Disclaimer*

Companies

GSK (GSK)
UK 100

Latest directors dealings